New model for possible malaria vaccination suggests mass vaccination for low transmission areas

January 17, 2012

In the event that a vaccine for the prevention of malaria is licensed and ready for use (such as the research malaria vaccine RTS,S, which currently looks promising), distributing and giving the vaccine to three-month old infants via the World Health Organization's Expanded Programme on Immunization (EPI) will be the most efficient mechanism in high transmission areas but for lower transmission areas, mass vaccination every 5 years might be a more efficient vaccination strategy, a new study has found.

In a modelling study led by Thomas Smith from the Public Health Institute in Basel, Switzerland, and published in this week's , the authors used 14 different models that simulated the transmission of the parasite that causes malaria (P. falciparum) in thousands of hypothetical individuals through different stages of . The authors used each model to predict the health benefits over 14 years of the potential malaria vaccine RTS,S given by different and found that the predicted benefits of giving the using the EPI strategy were modest and similar over a wide-range of settings. However, EPI with an initial catch-up phase averted the most deaths per vaccine dose in individuals who had over 10 infectious malaria bites a year but in areas where people typically have two or less infectious mosquito bites a year, the authors' model found that strategies substantially reduced transmission leading to much greater health effects per dose than other strategies, even at modest coverage.

This study only reports the first stages of using ensemble modelling to predict the health effects of RTS,S vaccination, so future studies will need to combine the outputs of multiple models with economic analyses to provide a rational basis for the design of vaccine-containing malaria control and elimination programs.

The authors say: "The ensemble modeling approach provides more robust outcomes than single models, and our analyses suggest that such an approach produces greater confidence in predictions of health effects for lower malaria transmission settings than for higher ones."

The authors continue: "This study suggests that targeted mass vaccination with RTS,S in low transmission settings may be more efficient than national-level introduction via EPI programs, but there remains a need to analyze the feasibility and economics of such strategies and the circumstances in which vaccination will avert epidemics."

Explore further: Potential for malaria transmission higher than previously thought

More information: Smith T, Ross A, Maire N, Chitnis N, Studer A, et al. (2012) Ensemble Modeling of the Likely Public Health Impact of a Pre-Erythrocytic Malaria Vaccine. PLoS Med 9(1): e1001157. doi:10.1371/journal.pmed.1001157

Related Stories

Clinical trial of malaria vaccine begins in Africa

May 25, 2011

The vaccine, RTS,S, developed by GlaxoSmithKline (GSK) Biologicals and PATH Malaria Vaccine Initiative (MVI), is currently in phase III clinical trials and has previously reduced episodes of malaria in infants and young children ...

Malaria vaccine shows promise: study

September 14, 2011

An experimental malaria vaccine tested on children in Burkina Faso has shown "a high level of efficacy" in protecting against the disease, a study published in the United States said Wednesday.

Recommended for you

Zika virus may persist in the vagina days after infection

August 25, 2016

The Zika virus reproduces in the vaginal tissue of pregnant mice several days after infection, according to a study by Yale researchers. From the genitals, the virus spreads and infects the fetal brain, impairing fetal development. ...

Team discovers how Zika virus causes fetal brain damage

August 24, 2016

Infection by the Zika virus diverts a key protein necessary for neural cell division in the developing human fetus, thereby causing the birth defect microcephaly, a team of Yale scientists reported Aug. 24 in the journal ...

Immune breakthrough: Unscratching poison ivy's rash

August 23, 2016

We all know that a brush with poison ivy leaves us with an itchy painful rash. Now, Monash University and Harvard researchers have discovered the molecular cause of this irritation. The finding brings us a step closer to ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Tausch
not rated yet Jan 17, 2012
Until then, genetically alter the carriers wingspan asymmetrically. If the GM carriers runs amok to all other species, then all species' flight are reduced to circular patterns. Eradication is superfluous. The food chain intact.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.